Literature DB >> 19477055

Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

David S Stephens1.   

Abstract

For at least two hundred years, Neisseria meningitidis (the meningococcus), the cause of epidemic meningitis and sepsis, has inflicted rapid death, disability and fear on disparate human populations. The meningococcus is also recognized as a highly successful commensal organism exclusively found in humans. The evolution of N. meningitidis as an exclusive human commensal and sometimes a fulminant and fatal pathogen represents an important case study in microbial pathogenesis. We review the general status of our knowledge of pathogenesis of meningococcal carriage, transmission and virulence behavior with particular emphasis on the relevance of research on this topic to vaccine development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477055      PMCID: PMC2712446          DOI: 10.1016/j.vaccine.2009.04.070

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  52 in total

1.  Serological relationships among meningococci.

Authors:  S E BRANHAM
Journal:  Bacteriol Rev       Date:  1953-09

2.  Epidemiology of nasopharyngeal carriage of Neisseria meningitidis in healthy Dutch children.

Authors:  D Bogaert; P W M Hermans; H Boelens; M Sluijter; A Luijendijk; H C Rumke; S Koppen; A van Belkum; R de Groot; H A Verbrugh
Journal:  Clin Infect Dis       Date:  2005-02-18       Impact factor: 9.079

3.  Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.

Authors:  Umeharu Ohto; Koichi Fukase; Kensuke Miyake; Yoshinori Satow
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

4.  Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.

Authors:  Pascal Boisier; Pierre Nicolas; Saacou Djibo; Muhamed-Kheir Taha; Isabelle Jeanne; Halima Boubacar Maïnassara; Bernard Tenebray; Kiari Kaka Kairo; Dario Giorgini; Suzanne Chanteau
Journal:  Clin Infect Dis       Date:  2007-01-25       Impact factor: 9.079

5.  Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group.

Authors:  M L Hibberd; M Sumiya; J A Summerfield; R Booy; M Levin
Journal:  Lancet       Date:  1999-03-27       Impact factor: 79.321

6.  Translocation and surface expression of lipidated serogroup B capsular Polysaccharide in Neisseria meningitidis.

Authors:  Yih-Ling Tzeng; Anup K Datta; Cristy A Strole; Michael A Lobritz; Russell W Carlson; David S Stephens
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins.

Authors:  Susu M Zughaier; Shanta M Zimmer; Anup Datta; Russell W Carlson; David S Stephens
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

8.  MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain.

Authors:  Philipp Oster; Diana Lennon; Jane O'Hallahan; Kim Mulholland; Stewart Reid; Diana Martin
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

9.  The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.

Authors:  Johan Holst; Berit Feiring; Lisbeth M Naess; Gunnstein Norheim; Paul Kristiansen; E Arne Høiby; Klaus Bryn; Philipp Oster; Paolo Costantino; Muhamed-Kheir Taha; Jean-Michel Alonso; Dominique A Caugant; Elisabeth Wedege; Ingeborg S Aaberge; Rino Rappuoli; Einar Rosenqvist
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

Review 10.  Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin).

Authors:  C M Kahler; D S Stephens
Journal:  Crit Rev Microbiol       Date:  1998       Impact factor: 7.624

View more
  81 in total

1.  An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  Sarika Agarwal; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 2.  A bacterial siren song: intimate interactions between Neisseria and neutrophils.

Authors:  Alison K Criss; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2012-01-31       Impact factor: 60.633

3.  Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production.

Authors:  Timm Fiebig; Friedrich Freiberger; Vittoria Pinto; Maria Rosaria Romano; Alan Black; Christa Litschko; Andrea Bethe; Dmitry Yashunsky; Roberto Adamo; Andrei Nikolaev; Francesco Berti; Rita Gerardy-Schahn
Journal:  J Biol Chem       Date:  2014-05-21       Impact factor: 5.157

4.  Virulence Traits of a Serogroup C Meningococcus and Isogenic cssA Mutant, Defective in Surface-Exposed Sialic Acid, in a Murine Model of Meningitis.

Authors:  Roberta Colicchio; Chiara Pagliuca; Susanna Ricci; Elena Scaglione; Denis Grandgirard; Ilias Masouris; Fabrizio Farina; Caterina Pagliarulo; Giuseppe Mantova; Laura Paragliola; Stephen L Leib; Uwe Koedel; Gianni Pozzi; Pietro Alifano; Paola Salvatore
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

Review 5.  Review of meningococcal vaccines with updates on immunization in adults.

Authors:  Yorgo C Zahlanie; Moza M Hammadi; Soha T Ghanem; Ghassan S Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

6.  Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.

Authors:  Matthew J Ferrari; Florence Fermon; Fabienne Nackers; Augusto Llosa; Claire Magone; Rebecca F Grais
Journal:  Int Health       Date:  2014-09-05       Impact factor: 2.473

Review 7.  Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.

Authors:  Mustapha M Mustapha; Lee H Harrison
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

8.  The capsule polymerase CslB of Neisseria meningitidis serogroup L catalyzes the synthesis of a complex trimeric repeating unit comprising glycosidic and phosphodiester linkages.

Authors:  Christa Litschko; Maria Rosaria Romano; Vittoria Pinto; Heike Claus; Ulrich Vogel; Francesco Berti; Rita Gerardy-Schahn; Timm Fiebig
Journal:  J Biol Chem       Date:  2015-08-18       Impact factor: 5.157

9.  Spectroscopic evidence for a 5-coordinate oxygenic ligated high spin ferric heme moiety in the Neisseria meningitidis hemoglobin binding receptor.

Authors:  David Z Mokry; Angela Nadia-Albete; Michael K Johnson; Gudrun S Lukat-Rodgers; Kenton R Rodgers; William N Lanzilotta
Journal:  Biochim Biophys Acta       Date:  2014-06-23

10.  Genealogical typing of Neisseria meningitidis.

Authors:  Xavier Didelot; Rachel Urwin; Martin C J Maiden; Daniel Falush
Journal:  Microbiology (Reading)       Date:  2009-07-30       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.